🔴 Cue Biopharma is trading 7.04% down today after reversing sharply from recent gains

Cue Biopharma is trading 7.04% down at $26.82 after reversing sharply from recent gains.

• The stock rose 15.44% on August 25 and 7.81% on August 26 before declining during August 27 trading.
• No new company-specific announcement dated August 27 was identified; investor relations lists its latest prominent releases as the August 3 CFO appointment and CUE-221 filing.
• The broader market is positive, and today’s drop appears to reflect profit-taking or stock-specific trading rather than broad market weakness.